3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
2
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
32
OTHER
25
NETWORK
2
FED
2
OTHER_GOV
1
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
2
Prostatic Diseases
1
Adenocarcinoma
1
Interventions
Specimen Handling
39
Magnetic Resonance Spectroscopy
30
Carboplatin
14
Biopsy
14
Radiation
13
Cyclophosphamide
13
Radiotherapy
11
daratumumab
10
Vincristine
10
Dexamethasone
10
Surgical Procedures, Operative
9
Etoposide
9
Lenalidomide
8
X-Rays
7
Observation
7
Leucovorin
7
Irinotecan
7
Doxorubicin
7
Cisplatin
7
durvalumab
6
dexamethasone acetate
6
dexamethasone 21-phosphate
6
auricularum
6
Watchful Waiting
6
Radiosurgery
6
Docetaxel
6
Calcium Dobesilate
6
pembrolizumab
5
Stem Cell Transplantation
5
Standard of Care
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
NETWORK
×
enzalutamide
×
Clear all
NCT06592924
2026-04-14
TRIPLE-SWITCH
Canadian Cancer Trials Group
Phase 3
Recruiting
830 enrolled
NCT06582628
2024-12-02
TEAM PC
Fundacion Oncosur
Phase 2
Recruiting
78 enrolled